,Year,Title,Altmetric
0,2021,Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovascular Disorders. 21.  2021  10.1186/s12872-021-02183-3,
1,2021,"Publisher Correction: Reappraising the role of inflammation in heart failure (Nature Reviews Cardiology, (2020), 17, 5, (269-285), 10.1038/s41569-019-0315-x). Nature Reviews Cardiology. 18:735.  2021  10.1038/s41569-021-00534-3",
2,2021,Cardiac pathology in COVID-19: a single center autopsy experience. Cardiovascular Pathology. 54.  2021  10.1016/j.carpath.2021.107370,
3,2021,Branched chain amino acids selectively promote cardiac growth at the end of the awake period. Journal of Molecular and Cellular Cardiology. 157:31-44.  2021  10.1016/j.yjmcc.2021.04.005,
4,2021,Healing and repair after myocardial infarction: The forgotten but resurgent basophil. Journal of Clinical Investigation. 131.  2021  10.1172/JCI150555,
5,2021,Relative Predictive Value of Circulating Immune Markers in US Adults Without Cardiovascular Disease: Implications for Risk Reclassification. Mayo Clinic Proceedings. 96:1812-1821.  2021  10.1016/j.mayocp.2020.11.027,
6,2021,Echocardiographic diagnosis of left ventricular diastolic dysfunction: Impact of coronary artery disease  2021  10.1111/echo.14959,
7,2021,Complete heart block without ventricular escape secondary to hyperkalemia induced by herbal tea. HeartRhythm Case Reports. 2021  10.1016/j.hrcr.2021.11.004,
8,2020,Cardiac Function and Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial). American Journal of Cardiology. 129:46-52.  2020  10.1016/j.amjcard.2020.04.038,
9,2020,Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas. ESC Heart Failure. 7:1676-1687.  2020  10.1002/ehf2.12724,
10,2020,"Clinical, Demographic, and Imaging Correlates of Anemia in Heart Failure With Preserved Ejection Fraction (from the RELAX Trial). American Journal of Cardiology. 125:1870-1878.  2020  10.1016/j.amjcard.2020.03.006",
11,2020,Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature. ESC Heart Failure. 7:1319-1330.  2020  10.1002/ehf2.12681,
12,2020,The apolipoprotein a-i mimetic l-4f attenuates monocyte activation and adverse cardiac remodeling after myocardial infarction. International Journal of Molecular Sciences. 21.  2020  10.3390/ijms21103519,
13,2020,"Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial). American Journal of Cardiology. 125:1347-1354.  2020  10.1016/j.amjcard.2020.01.046",
14,2020,Reappraising the role of inflammation in heart failure. Nature Reviews Cardiology. 17:269-285.  2020  10.1038/s41569-019-0315-x,
15,2020,MitoQ regulates redox-related noncoding RNAs to preserve mitochondrial network integrity in pressure-overload heart failure  2020  10.1152/ajpheart.00617.2019,
16,2020,"Intracellular metabolism analysis of Clostridium cellulovorans via modeling integrating proteomics, metabolomics and fermentation. Process Biochemistry. 89:9-19.  2020  10.1016/j.procbio.2019.10.032",
17,2020,The Evolution of the Enzymatic Diagnosis of Myocardial Infarction. American Journal of the Medical Sciences. 359:67-69.  2020  10.1016/j.amjms.2019.11.009,
18,2020,"Chronobiological influence over cardiovascular function the good, the bad, and the ugly. Circulation Research. 258-279.  2020  10.1161/CIRCRESAHA.119.313349",
19,2020,"Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients with Chronic Kidney Impairment. Circulation. 21-33.  2020  10.1161/CIRCULATIONAHA.119.043916",
20,2019,Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial  2019  10.1161/JAHA.119.012844,
21,2019,Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nature Communications. 10.  2019  10.1038/s41467-019-08895-7,
22,2019,Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention  2019  10.1161/JAHA.119.012874,
23,2019,"Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial. Circulation Research. 125:957-968.  2019  10.1161/CIRCRESAHA.119.315026",
24,2019,"Optimized protocols for isolation, fixation, and flow cytometric characterization of leukocytes in ischemic hearts  2019  10.1152/AJPHEART.00137.2019",
25,2019,"Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide. International Journal of Cardiology. 286:145-151.  2019  10.1016/j.ijcard.2019.02.034",
26,2019,"Response by Bansal et al to Letter Regarding Article, ""dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy"". Circulation. 139:E1035-E1036.  2019  10.1161/CIRCULATIONAHA.119.040737",
27,2019,Impact of medical therapy for cardiovascular disease on left ventricular diastolic properties and remodeling. International Journal of Cardiology: Heart and Vasculature. 23.  2019  10.1016/j.ijcha.2019.100365,
28,2019,Role of left ventricle deformation analysis in stress echocardiography for significant coronary artery disease detection: A diagnostic study meta-analysis  2019  10.1111/echo.14365,
29,2019,Cardiovascular Events and Hospital Deaths Among Patients With Severe Sepsis. American Journal of Cardiology. 123:1406-1413.  2019  10.1016/j.amjcard.2019.01.038,
30,2019,HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion injury. Journal of Molecular and Cellular Cardiology. 130:36-48.  2019  10.1016/j.yjmcc.2019.03.008,
31,2019,Evaluation of flow-modulation approaches in ventricular assist devices using an in-vitro endothelial cell culture model  2019  10.1016/j.healun.2018.10.007,
32,2019,Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice. Redox Biology. 21.  2019  10.1016/j.redox.2019.101100,
33,2019,Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy. Circulation. 139:206-221.  2019  10.1161/CIRCULATIONAHA.118.036065,
34,2019,Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure. Circulation Research. 124:161-169.  2019  10.1161/CIRCRESAHA.118.314216,
35,2019,Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS. JCI insight. 4.  2019  10.1172/jci.insight.129979,
36,2018,Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction. Journal of Molecular and Cellular Cardiology. 118:70-80.  2018  10.1016/j.yjmcc.2018.03.004,
37,2018,CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload. JACC: Basic to Translational Science. 3:230-244.  2018  10.1016/j.jacbts.2017.12.006,
38,2018,Effect of NT-proBNPâ€“Guided Therapy on All-Cause Mortality in Chronic Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology. 71:951-952.  2018  10.1016/j.jacc.2017.11.070,
39,2018,Racial differences in plasma levels of n-Terminal pro-b-Type natriuretic peptide and outcomes the reasons for geographic and racial differences in stroke (regards) study. JAMA Cardiology. 3:11-17.  2018  10.1001/jamacardio.2017.4207,
40,2018,Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes. Hypertension. 72:343-349.  2018  10.1161/HYPERTENSIONAHA.118.10965,
41,2018,THE CARDIOSPLENIC AXIS IS ESSENTIAL FOR THE PATHOGENESIS OF ISCHEMIC HEART FAILURE  2018,
42,2018,The stress kinase JNK regulates gap junction Cx43 gene expression and promotes atrial fibrillation in the aged heart. Journal of Molecular and Cellular Cardiology. 114:105-115.  2018  10.1016/j.yjmcc.2017.11.006,
43,2017,Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing. Scientific Reports. 7.  2017  10.1038/s41598-017-10441-8,
44,2017,Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering. Journal of the American College of Cardiology. 70:766-775.  2017  10.1016/j.jacc.2017.06.012,
45,2017,Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2-Hour Infusion in High-Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention  2017  10.1161/JAHA.117.005562,
46,2017,Continuous-Flow Left Ventricular Assist Device Support Improves Myocardial Supply:Demand in Chronic Heart Failure. Annals of Biomedical Engineering. 45:1475-1486.  2017  10.1007/s10439-017-1804-x,
47,2017,Immunomodulation is the key to cardiac repair. Circulation Research. 120:1530-1532.  2017  10.1161/CIRCRESAHA.117.310954,
48,2017,Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy. Basic Research in Cardiology. 112.  2017  10.1007/s00395-017-0612-7,
49,2017,Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure. Circulation: Heart Failure. 10.  2017  10.1161/CIRCHEARTFAILURE.116.003688,
50,2017,Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure. Basic Research in Cardiology. 112.  2017  10.1007/s00395-017-0609-2,
51,2017,"Myocardial ischemia/reperfusion impairs neurogenesis and hippocampal-dependent learning and memory. Brain, Behavior, and Immunity. 61:266-273.  2017  10.1016/j.bbi.2016.09.001",
52,2017,Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone. International Journal of Cardiology. 227:462-466.  2017  10.1016/j.ijcard.2016.11.006,
53,2017,Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation. Journal of Molecular and Cellular Cardiology. 102:83-93.  2017  10.1016/j.yjmcc.2016.12.002,
54,2017,Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing  2017  10.1152/ajpheart.00040.2017,
55,2017,Mononuclear phagocytes are dispensable for cardiac remodeling in established pressure-overload heart failure. PLoS ONE. 12.  2017  10.1371/journal.pone.0170781,
56,2016,Altered myocardial metabolic adaptation to increased fatty acid availability in cardiomyocyte-specific CLOCK mutant mice  2016  10.1016/j.bbalip.2015.12.012,
57,2016,Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure. American Journal of Medicine. 129:1067-1073.  2016  10.1016/j.amjmed.2016.05.008,
58,2016,Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin. American Journal of Cardiology. 118:232-236.  2016  10.1016/j.amjcard.2016.04.047,
59,2016,The biological basis for cardiac repair after myocardial infarction. Circulation Research. 119:91-112.  2016  10.1161/CIRCRESAHA.116.303577,
60,2016,Acute metabolic influences on the natriuretic peptide system in humans. Journal of the American College of Cardiology. 67:804-812.  2016  10.1016/j.jacc.2015.11.049,
61,2016,Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction. Aging. 8:2611-2634.  2016  10.18632/aging.101077,
62,2016,Heme oxygenase-1 regulates mitochondrial quality control in the heart.. JCI insight. 1:e85817.  2016  10.1172/jci.insight.85817,
63,2016,TNF receptor signaling inhibits cardiomyogenic differentiation of cardiac stem cells and promotes a neuroadrenergic-like fate  2016  10.1152/ajpheart.00904.2015,
64,2015,O-GlcNAcylation negatively regulates cardiomyogenic fate in adult mouse cardiac mesenchymal stromal cells. PLoS ONE. 10.  2015  10.1371/journal.pone.0142939,
65,2015,Residential Proximity to Major Roadways Is Associated with Increased Levels of AC133+ Circulating Angiogenic Cells  2015  10.1161/ATVBAHA.115.305724,
66,2015,Genetic Deficiency of Glutathione S-Transferase P Increases Myocardial Sensitivity to Ischemia-Reperfusion Injury. Circulation Research. 117:437-449.  2015  10.1161/CIRCRESAHA.114.305518,
67,2015,Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure. American Journal of Medicine. 128:715-721.  2015  10.1016/j.amjmed.2014.11.036,
68,2015,Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. Journal of Molecular and Cellular Cardiology. 84:24-35.  2015  10.1016/j.yjmcc.2015.04.003,
69,2015,Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice. Toxicology and Applied Pharmacology. 285:136-148.  2015  10.1016/j.taap.2015.03.029,
70,2015,Pretransplant coagulopathy and in-hospital outcomes among heart transplant recipients: A propensity-matched nationwide inpatient sample study  2015  10.1002/clc.22391,
71,2015,Reply: Upgrade Ambulatory Extra-Aortic Counterpulsation to Full-Support LVAD. JACC: Heart Failure. 3:343-344.  2015  10.1016/j.jchf.2014.12.011,
72,2015,"Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation  2015  10.1152/ajpheart.00608.2015",
73,2015,Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the veterans affairs versus other hospitals insights from the Beta-blocker Evaluation of Survival Trial (BEST). Circulation: Heart Failure. 8:17-24.  2015  10.1161/CIRCHEARTFAILURE.114.001300,
74,2014,Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Research in Cardiology. 109.  2014  10.1007/s00395-014-0444-7,
75,2014,Ambulatory extra-aortic counterpulsation in patients with moderate to severe chronic heart failure. JACC: Heart Failure. 2:526-533.  2014  10.1016/j.jchf.2014.04.014,
76,2014,"Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults. American Journal of Cardiology. 114:909-913.  2014  10.1016/j.amjcard.2014.05.045",
77,2014,Metabolomic analysis of pressure-overloaded and infarcted mouse hearts. Circulation: Heart Failure. 7:634-642.  2014  10.1161/CIRCHEARTFAILURE.114.001151,
78,2014,"Spironolactone use and higher hospital readmission for medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m2. American Journal of Cardiology. 114:79-82.  2014  10.1016/j.amjcard.2014.03.062",
79,2014,Inhibiting Na+/K+ ATPase can impair mitochondrial energetics and induce abnormal Ca2+ cycling and automaticity in guinea pig cardiomyocytes. PLoS ONE. 9.  2014  10.1371/journal.pone.0093928,
80,2014,Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure. American Journal of Medicine. 127:132-139.  2014  10.1016/j.amjmed.2013.08.006,
81,2014,Acrolein exposure is associated with increased cardiovascular disease risk  2014  10.1161/JAHA.114.000934,
82,2014,Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction. STEM CELLS. 32:2502-2515.  2014  10.1002/stem.1743,
83,2014,"Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults.. American Journal of Cardiology. 114:909-913.  2014",
84,2014,It takes two to tango: Monocyte and macrophage duality in the infarcted heart. Circulation Research. 114:1558-1560.  2014  10.1161/CIRCRESAHA.114.303933,
85,2014,Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure critical importance of the cardiosplenic axis. Circulation Research. 114:266-282.  2014  10.1161/CIRCRESAHA.113.301720,
86,2013,Bovine Model of Chronic Ischemic Cardiomyopathy: Implications for Ventricular Assist Device Research  2013  10.1111/aor.12129,
87,2013,Cardiac immune cell remodeling after myocardial infarction. Journal of Molecular and Cellular Cardiology. 62:142-143.  2013  10.1016/j.yjmcc.2013.05.017,
88,2013,Heme oxygenase-1 expression protects the heart from acute injury caused by inducible Cre recombinase. Laboratory Investigation. 93:868-879.  2013  10.1038/labinvest.2013.74,
89,2013,Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. STEM CELLS. 31:765-775.  2013  10.1002/stem.1325,
90,2013,H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation. 127:1116-1127.  2013  10.1161/CIRCULATIONAHA.112.000855,
91,2012,Reply to the editor. Journal of Thoracic and Cardiovascular Surgery. 144:1531-1533.  2012  10.1016/j.jtcvs.2012.08.045,
92,2012,Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion. Basic Research in Cardiology. 107.  2012  10.1007/s00395-012-0305-1,
93,2012,Mechanism of myocardial ischemia with an anomalous left coronary artery from the right sinus of Valsalva. Journal of Thoracic and Cardiovascular Surgery. 144:402-408.  2012  10.1016/j.jtcvs.2011.08.056,
94,2012,O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy  2012  10.1152/ajpheart.00775.2011,
95,2012,"Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase c/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner. Journal of the American College of Cardiology. 59:1477-1486.  2012  10.1016/j.jacc.2011.12.034",
96,2012,Statistical Analysis of Repeated MicroRNA High-Throughput Data with Application to Human Heart Failure: A Review of Methodology.. Open Access Medical Statistics. 2012:21-31.  2012  10.2147/OAMS.S27907,
97,2012,Animal models of heart failure a scientific statement from the American Heart Association. Circulation Research. 111:131-150.  2012  10.1161/RES.0b013e3182582523,
98,2012,Direct measurement of blood flow in microvessels grown in Matrigel in vivo. Journal of Surgical Research. 172.  2012  10.1016/j.jss.2011.09.010,
99,2011,Endothelial cell culture model of carotid artery atherosclerosis. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference. 186-189.  2011  10.1109/IEMBS.2011.6089925,
100,2011,Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy  2011  10.1152/ajpheart.00120.2011,
101,2011,Tumor necrosis factor receptor 2 signaling limits Î²-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Research in Cardiology. 106:1193-1205.  2011  10.1007/s00395-011-0196-6,
102,2011,Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology. 50:928-938.  2011  10.1016/j.yjmcc.2011.02.012,
103,2011,Heart transplant vs left ventricular assist device in heart transplant-eligible patients. Annals of Thoracic Surgery. 91:1330-1334.  2011  10.1016/j.athoracsur.2011.01.062,
104,2011,"Endothelial cell culture model for replication of physiological profiles of pressure, flow, stretch, and shear stress in vitro. Analytical Chemistry. 83:3170-3177.  2011  10.1021/ac2002998",
105,2011,Bovine model of doxorubicin-induced cardiomyopathy. Journal of Biomedicine and Biotechnology. 2011.  2011  10.1155/2011/758736,
106,2011,"Cardiomyocyte NF-ÎºB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovascular Research. 89:129-138.  2011  10.1093/cvr/cvq274",
107,2011,Environmental pollutants and heart failure. Issues in Toxicology. 177-197.  2011,
108,2011,Microfluidic endothelial cell culture model to replicate disturbed flow conditions seen in atherosclerosis susceptible regions. Biomicrofluidics. 5.  2011  10.1063/1.3608137,
109,2011,Mitral valve prolapse after long-term mechanical ventricular unloading  2011  10.1016/j.healun.2011.02.010,
110,2011,"Response to Letter to the Editor: A Novel Subcutaneous Counterpulsation Device: Acute Hemodynamic Efficacy During Pharmacologically Induced Hypertension, Hypotension, and Heart Failure  2011  10.1111/j.1525-1594.2010.01184.x",
111,2010,O-linked Î²-N-acetylglucosamine transferase is indispensable in the failing heart  2010  10.1073/pnas.1001907107,
112,2010,Chronic AMD3100 antagonism of SDF-1Î±-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction. Journal of Molecular and Cellular Cardiology. 49:587-597.  2010  10.1016/j.yjmcc.2010.07.010,
113,2010,"EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-ÎšB andMKK7/JNK/AP-1 signaling. Journal of Molecular and Cellular Cardiology. 49:655-663.  2010  10.1016/j.yjmcc.2010.05.007",
114,2010,Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-ÎºB activation  2010  10.1152/ajpheart.00451.2010,
115,2010,Microfluidic Cardiac Cell Culture Model (Î¼CCCM). Analytical Chemistry. 82:7581-7587.  2010  10.1021/ac1012893,
116,2010,Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle. ASAIO Journal. 56:410-416.  2010  10.1097/MAT.0b013e3181e7bf3c,
117,2010,Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload. Free Radical Biology and Medicine. 49:401-407.  2010  10.1016/j.freeradbiomed.2010.04.033,
118,2010,Erythropoietin and ventricular remodelling: A VEGF-dependent neovascularity. Cardiovascular Research. 87:6-7.  2010  10.1093/cvr/cvq127,
119,2010,Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation. 121:1912-1925.  2010  10.1161/CIRCULATIONAHA.109.905471,
120,2010,WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cellular Signalling. 22:809-820.  2010  10.1016/j.cellsig.2010.01.005,
121,2010,"A novel subcutaneous counterpulsation device: Acute hemodynamic efficacy during pharmacologically induced hypertension, hypotension, and heart failure  2010  10.1111/j.1525-1594.2010.01009.x",
122,2009,"Microfluidic cardiac circulation model (Î¼CCM) for functional cardiomyocyte studies. Proceedings of the 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society: Engineering the Future of Biomedicine, EMBC 2009. 1060-1063.  2009  10.1109/IEMBS.2009.5334997",
123,2009,O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death  2009  10.1152/ajpheart.00553.2009,
124,2009,Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury. Journal of Biological Chemistry. 284:7853-7865.  2009  10.1074/jbc.M808824200,
125,2009,Divergent tumor necrosis factor receptor-related remodeling responses in heart failure:Role of nuclear factor-ÎºB and inflammatory activation. Circulation. 119:1386-1397.  2009  10.1161/CIRCULATIONAHA.108.802918,
126,2009,Intraoperative Evaluation of the HeartMate II Flow Estimator  2009  10.1016/j.healun.2008.10.007,
127,2008,"Human, Bovine and Porcine Systematic Vascular Input Impedances Are Not Equivalent: Implications for Device Testing and Xenotransplantation in Heart Failure  2008  10.1016/j.healun.2008.08.009",
128,2008,Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation. 118:1970-1978.  2008  10.1161/CIRCULATIONAHA.108.791533,
129,2008,Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function. ASAIO Journal. 54:578-584.  2008  10.1097/MAT.0b013e318186891f,
130,2008,Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-ÎºB/PTEN suppression. Journal of Biological Chemistry. 283:24889-24898.  2008  10.1074/jbc.M804236200,
131,2008,"Metallothionein Suppresses Angiotensin II-Induced Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activation, Nitrosative Stress, Apoptosis, and Pathological Remodeling in the Diabetic Heart. Journal of the American College of Cardiology. 52:655-666.  2008  10.1016/j.jacc.2008.05.019",
132,2008,Postnatal intermittent hypoxia and developmental programming of hypertension in spontaneously hypertensive Rats: The role of reactive oxygen species and L-Ca 2+ channels. Hypertension. 52:156-162.  2008  10.1161/HYPERTENSIONAHA.108.110296,
133,2008,Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCÎµ signaling and cardioprotection. Journal of Molecular and Cellular Cardiology. 44:1016-1022.  2008  10.1016/j.yjmcc.2008.03.020,
134,2008,Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts  2008  10.1152/ajpheart.01363.2007,
135,2008,A True Emergency?. American Journal of Medicine. 121:290-292.  2008  10.1016/j.amjmed.2007.09.011,
136,2007,Mechanisms of acrolein-induced myocardial dysfunction: Implications for environmental and endogenous aldehyde exposure  2007  10.1152/ajpheart.00284.2007,
137,2007,Diabetic cardiomyopathy in OVE26 mice shows mitochondrial ROS production and divergence between in vivo and in vitro contractility  2007  10.1900/RDS.2007.4.159,
138,2007,Downregulation of CuZn-superoxide dismutase contributes to Î²-adrenergic receptor-mediated oxidative stress in the heart. Cardiovascular Research. 74:445-455.  2007  10.1016/j.cardiores.2007.02.016,
139,2007,Altered left ventricular-arterial coupling precedes pump dysfunction in early heart failure  2007  10.1007/s00380-006-0954-9,
140,2007,Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device. Journal of Thoracic and Cardiovascular Surgery. 133:517-524.  2007  10.1016/j.jtcvs.2006.09.057,
141,2006,Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circulation Research. 98:1098-1105.  2006  10.1161/01.RES.0000218454.76784.66,
142,2006,Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation. 113:544-554.  2006  10.1161/CIRCULATIONAHA.105.537894,
143,2006,Prolonged oxidative stress inverts the cardiac force-frequency relation: Role of altered calcium handling and myofilament calcium responsiveness. Journal of Molecular and Cellular Cardiology. 40:64-75.  2006  10.1016/j.yjmcc.2005.09.013,
144,2005,Allopurinol and heart failure: A new use for an old drug?. Journal of Molecular and Cellular Cardiology. 39:407-409.  2005  10.1016/j.yjmcc.2005.05.011,
145,2005,"Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function  2005  10.1073/pnas.0405957102",
146,2005,Post-infarction ventricular remodeling: An array of molecular events. Journal of Molecular and Cellular Cardiology. 38:547-550.  2005  10.1016/j.yjmcc.2005.01.014,
147,2004,Cytokine-induced modulation of cardiac function. Circulation Research. 95:1140-1153.  2004  10.1161/01.RES.0000150734.79804.92,
148,2004,"Cardiac functional analysis by electrocardiography, echocardiography and in situ hemodynamics in streptozotocin-induced diabetic mice  2004  10.1248/jhs.50.356",
149,2004,"Î²-Adrenergic stimulation induces interleukin-18 expression via Î²2-AR, PI3K, Akt, IKK, and NF-ÎºB. Biochemical and Biophysical Research Communications. 319:304-311.  2004  10.1016/j.bbrc.2004.04.185",
150,2004,Nitric oxide protects against pathological ventricular remodeling: Reconsideration of the role of NO in the failing heart. Circulation Research. 94:1155-1157.  2004  10.1161/01.RES.0000129569.07667.89,
151,2004,Strategies for Developing Biomarkers of Heart Failure  2004  10.1373/clinchem.2003.027557,
152,2003,Cardiac Toxic Effects of Trans-2-Hexenal are Mediated by Induction of Cardiomyocyte Apoptotic Pathways. Cardiovascular Toxicology. 3:341-351.  2003  10.1385/CT:3:4:341,
153,2003,Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium.. Journal of Molecular and Cellular Cardiology. 35:483-493.  2003  10.1016/s0022-2828(03)00052-x,
154,2003,Î²-Adrenergic receptor blockade modulates Bcl-XS expression and reduces apoptosis in failing myocardium. Journal of Molecular and Cellular Cardiology. 35:483-493.  2003  10.1016/S0022-2828(03)00052-X,
155,2003,Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circulation Research. 92:741-748.  2003  10.1161/01.RES.0000065441.72685.29,
156,2002,Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: Role of aldose reductase  2002  10.1152/ajpheart.00592.2002,
157,2002,Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase.  2002  10.1152/ajpheart.00592.2002,
158,2002,Images in cardiology: Anomalous origin of a diseased left main coronary artery from the right sinus of Valsalva  2002  10.1002/clc.4960251011,
159,2002,Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor. Circulation Research. 91:165-172.  2002  10.1161/01.RES.0000028007.91385.EE,
160,2000,Chronic Î²-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation. 101:2338-2341.  2000  10.1161/01.CIR.101.20.2338,
161,2000,"beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.. Circulation. 101:2103-2109.  2000  10.1161/01.cir.101.17.2103",
162,2000,"Î²-Adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation. 101:2103-2109.  2000  10.1161/01.CIR.101.17.2103",
163,2000,Altered LV inotropic reserve and mechanoenergetics early in the development of heart failure.  2000  10.1152/ajpheart.2000.278.3.H698,
164,2000,Altered LV inotropic reserve and mechanoenergetics early in the development of heart failure  2000  10.1152/ajpheart.2000.278.3.h698,
165,1999,Hemodynamic effects of nitric oxide synthase inhibition at steady state and following tumor necrosis factor-Î±-induced myodepression. Cardiovascular Research. 44:527-535.  1999  10.1016/S0008-6363(99)00226-6,
166,1999,Load sensitivity of left ventricular relaxation in normal and failing hearts: Evidence of a nonlinear biphasic response. Cardiovascular Research. 43:354-363.  1999  10.1016/S0008-6363(99)00102-9,
167,1999,Nitric oxide effects on myocardial function and force-interval relations: Regulation of twitch duration. Journal of Molecular and Cellular Cardiology. 31:2077-2085.  1999  10.1006/jmcc.1999.1038,
168,1998,Ryanodine and the left ventricular force-interval and relaxation- interval relations in closed-chest dogs: Insights on calcium handling. Cardiovascular Research. 40:483-491.  1998  10.1016/S0008-6363(98)00201-6,
169,1997,Ryanodine and left ventricular function in intact dogs: dissociation of force-based and velocity-based indexes.. American Journal of Physiology. 273:H1561-H1568.  1997  10.1152/ajpheart.1997.273.3.H1561,
170,1997,Syncope: current diagnosis and treatment.. Current Problems in Cardiology. 22:242-296.  1997  10.1016/s0146-2806(97)80008-4,
171,1997,Ryanodine and left ventricular function in intact dogs: Dissociation of force-based and velocity-based indexes  1997  10.1152/ajpheart.1997.273.3.h1561,
172,1997,Syncope: Current diagnosis and treatment. Current Problems in Cardiology. 22:237-296.  1997,
173,1997,Syncope: Current diagnosis and treatment. Current Problems in Cardiology. 22:237-296.  1997  10.1016/s0146-2806(97)80008-4,
174,1996,Proliferative properties of smc cultures derived from de novo and restenotic human coronary lesions. The FASEB Journal. 10.  1996,
175,1995,Postextrasystolic mechanical restitution in closed-chest dogs: Effect of heart failure. Circulation. 92:2652-2659.  1995  10.1161/01.CIR.92.9.2652,
176,1995,Effect of tachycardia heart failure on the restitution of left ventricular function in closed-chest dogs. Circulation. 91:176-185.  1995  10.1161/01.cir.91.1.176,
177,1993,Left ventricular energetics in closed-chest dogs.. American Journal of Physiology. 265:H1048-H1055.  1993  10.1152/ajpheart.1993.265.4.H1048,
178,1993,An analysis of variability of left ventricular pressure decay. American Journal of Physiology. 264.  1993  10.1152/ajpheart.1993.264.1.h262,
179,1993,An analysis of variability of left ventricular pressure decay.. American Journal of Physiology. 264:H262-H268.  1993  10.1152/ajpheart.1993.264.1.H262,
180,1993,Determination of ventricular elastance with echocardiography: A reality?. American Heart Journal. 126:500-502.  1993  10.1016/0002-8703(93)91085-S,
181,1993,Left ventricular energetics in closed-chest dogs. American Journal of Physiology. 265.  1993  10.1152/ajpheart.1993.265.4.h1048,
182,1992,Kinetics of restitution of left ventricular relaxation. Circulation Research. 70:29-38.  1992  10.1161/01.RES.70.1.29,
183,1990,Reactive disulfide compounds induce Ca2+ release from cardiac sarcoplasmic reticulum. Archives of Biochemistry and Biophysics. 282:275-283.  1990  10.1016/0003-9861(90)90117-H,
184,1990,The heavy metal ions Ag+ and Hg2+ trigger calcium release from cardiac sarcoplasmic reticulum. Archives of Biochemistry and Biophysics. 277:47-55.  1990  10.1016/0003-9861(90)90548-D,
